专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

EP1271620B1 Method and apparatus for heat treatment of semiconductor films 有权
标题翻译：对半导体膜的热处理的方法和装置
公开(公告)号：EP1271620B1
公开(公告)日：2013-05-29
申请号：EP01420142.0
申请日：2001-06-21
申请人： Kim, Hyoung June
发明人： Kim, Hyoung June
IPC分类号： H01L21/67 , C30B25/10
CPC分类号： H01L21/67115

2. 发明公开

EP1271620A1 Method and apparatus for heat treatment of semiconductor films 有权
标题翻译： Verfahren und Vorrichtung zurWärmebehandlungvon Halbleiterfilmen
公开(公告)号：EP1271620A1
公开(公告)日：2003-01-02
申请号：EP01420142.0
申请日：2001-06-21
申请人： Kim, Hyoung June
发明人： Kim, Hyoung June
IPC分类号： H01L21/00 , C30B25/10
CPC分类号： H01L21/67115
摘要： The present invention relates to methods and apparatuses for heat treatment of semiconductor films upon thermally susceptible non-conducting substrates at a minimum thermal budget are required, and more particularly, to a polycrystalline silicon thin-film transistors (poly-Si TFTs) and PN diodes on glass substrates for various applications of liquid crystal displays (LCDs), organic light emitting diodes (OLEDs), and solar cells. According to the methods and apparatus of the present invention, the semiconductor films can be heat-treated without damaging the thermally susceptible substrates: e.g., crystallization of amorphous silicon films at the minimum thermal budget acceptable for the use of glass, enhancing kinetics of dopant activation at the minimum thermal budget acceptable for the use of glass.
摘要翻译：本发明涉及用于在热敏非导电基板上以最小热量预算对半导体膜进行热处理的方法和装置，更具体地涉及多晶硅薄膜晶体管（多晶硅TFT）和PN二极管在用于液晶显示器（LCD），有机发光二极管（OLED）和太阳能电池的各种应用的玻璃基板上。根据本发明的方法和装置，可以对半导体膜进行热处理，而不会损害耐热敏基板：例如，在玻璃的使用可接受的最小热预算下非晶硅膜的结晶化，增强掺杂剂激活的动力学在玻璃使用的最低热预算可接受。

3. 发明申请

WO2012074202A2 METHOD OF SCREENING MATERIAL FOR IMPROVING DRY SKIN USING BLEOMYCIN HYDROLASE 审中-公开
标题翻译：筛选使用双酚A水解酶改善干性皮肤的材料的方法
公开(公告)号：WO2012074202A2
公开(公告)日：2012-06-07
申请号：PCT/KR2011007937
申请日：2011-10-24
申请人： AMOREPACIFIC CORP , SON EUI DONG , KIM YOON KYUNG , JOO KYUNG MI , KIM HYOUNG JUNE , LEE EUN KYUNG , NAM GAE WON , KIM JI HYUN , AHN SOO MI , KIM HAN KON
发明人： SON EUI DONG , KIM YOON KYUNG , JOO KYUNG MI , KIM HYOUNG JUNE , LEE EUN KYUNG , NAM GAE WON , KIM JI HYUN , AHN SOO MI , KIM HAN KON
IPC分类号： C12Q1/34 , A61K8/46 , A61Q19/00 , C12Q1/68
CPC分类号： G01N33/573 , G01N2333/96466 , G01N2800/20
摘要： The present invention relates to a method of screening material for improving dry skin and provides a method of screening material for improving dry skin comprising screening on the basis of a change in gene expression of bleomycin hydrolase by a candidate material, and a material for improving dry skin found by screening. In addition, provided is a composition for a skin preparation for external use, containing a liver X receptor activator which increases the gene expression of bleomycin hydrolase as an active ingredient. The screening method of the present invention can find an effective material for improving dry skin, and the composition improves dry skin and prevents loss of skin moisture, thereby restoring the skin barrier of the stratum corneum.
摘要翻译：本发明涉及一种筛选用于改善干性皮肤的材料的方法，并提供一种筛选用于改善干性皮肤的材料的方法，包括基于候选材料对博来霉素水解酶的基因表达的变化进行筛选，以及用于改善干性通过筛选发现皮肤。此外，提供了用于外用皮肤制剂的组合物，其含有增加作为活性成分的博来霉素水解酶的基因表达的肝X受体激活剂。本发明的筛选方法可以找到用于改善干性皮肤的有效材料，并且该组合物改善干性皮肤并防止皮肤水分的损失，从而恢复角质层的皮肤屏障。

4. 发明申请

WO2011062456A2 COMPOSITION FOR BLOCKING ULTRAVIOLET C(UV-C) RADIATION 审中-公开
标题翻译：用于阻断超紫外线C（UV-C）辐射的组合物
公开(公告)号：WO2011062456A2
公开(公告)日：2011-05-26
申请号：PCT/KR2010008271
申请日：2010-11-23
申请人： AMOREPACIFIC CORP , KIM HYOUNG JUNE , OH TAEK JIN , SON EUI DONG , LEE HAE KWANG , KIM YOON KYUNG , CHOI HYUN , NOH MIN SOO , KIM HAN KON
发明人： KIM HYOUNG JUNE , OH TAEK JIN , SON EUI DONG , LEE HAE KWANG , KIM YOON KYUNG , CHOI HYUN , NOH MIN SOO , KIM HAN KON
IPC分类号： A61K8/37 , A61K8/49 , A61Q17/04
CPC分类号： A61Q17/04 , A61K8/37 , A61K8/4946
摘要： The present invention relates to a composition for blocking ultraviolet C(UV-C) radiation comprising one or more selected from the group consisting of octyl salicylate and phenyl benzimidazole sulfonic acid as an active ingredient.
摘要翻译：本发明涉及一种用于阻断紫外线（UV-C）辐射的组合物，其包含选自水杨酸辛酯和苯基苯并咪唑磺酸作为活性成分的一种或多种。

5. 发明申请

WO2008069518A1 PHARMACEUTICAL COMPOSITION FOR CONTROLLING THE FUNCTION OF SPIHNGOSYLPHOSPHORYLCHOLINE 审中-公开
标题翻译：用于控制SPIHNGOSYLPHOSPHORLCHOLINE功能的药物组合物
公开(公告)号：WO2008069518A1
公开(公告)日：2008-06-12
申请号：PCT/KR2007/006188
申请日：2007-12-03
申请人： AMOREPACIFIC CORPORATION , SBSCIENCE INC. , SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION , KO, Jaeyoung , KIM, Hyuk , KIM, Kwang Mi , NOH, Minsoo , LEE, Chang-hoon , KIM, Jung Ju , KIM, Hyoung June , CHO, Sun A , SUNG, Ki Sa , KIM, Dae-Kwon , SHIN, Jae-min , CHO, Doo Ho , KIM, Sanghee , LIM, Chaemin
发明人： KO, Jaeyoung , KIM, Hyuk , KIM, Kwang Mi , NOH, Minsoo , LEE, Chang-hoon , KIM, Jung Ju , KIM, Hyoung June , CHO, Sun A , SUNG, Ki Sa , KIM, Dae-Kwon , SHIN, Jae-min , CHO, Doo Ho , KIM, Sanghee , LIM, Chaemin
IPC分类号： C07C217/16
CPC分类号： A61K31/138
摘要： The present invention relates to a new use of alkylcarbamoyl naphthalenyloxyprophenylhydroxybenzamide derivatives for controlling the function of sphingosylphosphorylcholine.
摘要翻译：本发明涉及烷基氨基甲酰基萘氧基苯基羟基苯甲酰胺衍生物用于控制鞘糖基磷酰胆碱功能的新用途。

6. 发明申请

WO2006049416A1 USE OF METABOLITES OF ARACHIDONIC ACID OR THE DERIVATIVE THEREOF 审中-公开
标题翻译：使用芳香酸或其衍生物的代谢物
公开(公告)号：WO2006049416A1
公开(公告)日：2006-05-11
申请号：PCT/KR2005/003648
申请日：2005-11-01
申请人： AMOREPACIFIC CORPORATION , KIM, Dae, kwon , YUN, Jun, Won , KIM, Hyoung, June , PARK, Won, Seok , SUNG, Dae, Seok , YANG, Hye, Jin , KIM, Kwang, Mi , LEE, Chang, Hoon , SIM, Young, Chul
发明人： KIM, Dae, kwon , YUN, Jun, Won , KIM, Hyoung, June , PARK, Won, Seok , SUNG, Dae, Seok , YANG, Hye, Jin , KIM, Kwang, Mi , LEE, Chang, Hoon , SIM, Young, Chul
IPC分类号： A61K31/202 , A61P17/04
CPC分类号： A61K31/202
摘要： The present invention relates to a use of metabolites of arachidonic acid or derivatives thereof, more particularly to a process for inducing an itch in an animal, a process for screening an anti-itching substance and a process for evaluating the anti-itching effect of an anti-itching substance, by regulating the administration of 12(s)-HPETE or 15(s)-HPETE, which are the metabolites of arachidonic acid, or derivatives thereof. The metabolites of arachidonic acid or derivatives thereof according to the present invention are useful in understanding an itch, for screening the therapeutic candidates for itch, and for evaluating and developing such agent.
摘要翻译：本发明涉及花生四烯酸或其衍生物的代谢物的用途，更具体地涉及诱导动物瘙痒的方法，用于筛选抗瘙痒物质的方法和评价抗瘙痒效果的方法通过调节作为花生四烯酸的代谢物或其衍生物的12（s）-HPETE或15（s）-HPETE的施用来防止瘙痒物质。根据本发明的花生四烯酸或其衍生物的代谢物可用于理解瘙痒，筛选瘙痒的治疗候选物以及用于评价和开发该药剂。

7. 发明申请

WO2012008747A3 SKIN DIAGNOSIS METHOD AND KIT 审中-公开
标题翻译：皮肤诊断方法和包装
公开(公告)号：WO2012008747A3
公开(公告)日：2012-08-23
申请号：PCT/KR2011005147
申请日：2011-07-13
申请人： AMOREPACIFIC CORP , KIM SHIN HYOUNG , OH TAEK JIN , KIM HYOUNG JUNE , SON EUI DONG , KANG BYUNG YOUNG
发明人： KIM SHIN HYOUNG , OH TAEK JIN , KIM HYOUNG JUNE , SON EUI DONG , KANG BYUNG YOUNG
IPC分类号： G01N33/68 , A61B10/02 , G01N33/52
CPC分类号： A61B10/02 , G01N33/6893 , G01N2800/20
摘要： The present invention relates to a method for diagnosing skin conditions, comprising: a step of collecting skin or a skin secretion; and a step of measuring a biomarker of the skin or skin secretion collected in the previous step. The present invention also relates to a kit for diagnosing skin conditions, comprising: a unit for collecting skin or skin secretions; and a measuring unit which measures a biomarker of the skin or skin secretion. Skin conditions can be easily, conveniently, and quickly measured using the above-described method for diagnosing skin conditions and the kit for diagnosing skin conditions.
摘要翻译：本发明涉及一种诊断皮肤病症的方法，包括：收集皮肤或皮肤分泌物的步骤; 以及测量在前一步骤中收集的皮肤或皮肤分泌物的生物标志物的步骤。本发明还涉及用于诊断皮肤病症的试剂盒，其包括：用于收集皮肤或皮肤分泌物的单元; 以及测量皮肤或皮肤分泌生物标志物的测量单元。使用上述用于诊断皮肤状况的方法和用于诊断皮肤状况的试剂盒，可以容易地，方便地且快速地测量皮肤状况。

8. 发明申请

WO2009041790A1 NOVEL 2,4,5-TRISUBTITUTED-1,3-THIAZOLE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARATION, THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE INDUCED BY SPC ACTIVITY CONTAINING 2,4,5- TRISUBSTITUTED-1,3-THIAZOLE DERIVATIVES AS AN EFFECTIVE INGREDIENT 审中-公开
标题翻译：新的2,4,5-三唑-1,3-二噻唑衍生物及其药学上可接受的盐，其制备方法，由包含2,4,5-三唑基-1,3-噻唑衍生物的SPC活性诱发的炎症疾病的治疗剂一个
公开(公告)号：WO2009041790A1
公开(公告)日：2009-04-02
申请号：PCT/KR2008/005726
申请日：2008-09-26
申请人： KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY , AMOREPACIFIC CORPORATION , GONG, Young-Dae , CHO, Heeyeong , JEON, Moon-Kook , LEE, Taeho , CHOI, Gildon , KONG, Jae-Yang , JEONG, Dae Young , HWANG, Soon-Hee , KIM, Jung Ju , LEE, Chang-hoon , KO, Jaeyoung , NOH, Minsoo , HAN, Eun Sil , KIM, Hyoung June , KIM, Hyuk , YUN, Jun-Won , MOH, Joo Hyun , KIM, Do Hoon
发明人： GONG, Young-Dae , CHO, Heeyeong , JEON, Moon-Kook , LEE, Taeho , CHOI, Gildon , KONG, Jae-Yang , JEONG, Dae Young , HWANG, Soon-Hee , KIM, Jung Ju , LEE, Chang-hoon , KO, Jaeyoung , NOH, Minsoo , HAN, Eun Sil , KIM, Hyoung June , KIM, Hyuk , YUN, Jun-Won , MOH, Joo Hyun , KIM, Do Hoon
IPC分类号： C07D277/44 , A61K31/426 , A61P29/00
CPC分类号： C07D277/46 , C07D417/04 , C07D417/12
摘要： Provided are a 2,4,5-trisubstiuted-l,3-thiazole derivative represented by the following Chemical Formula 1, a pharmaceutically acceptable salt thereof, a method for preparation thereof, and a use thereof as an effective ingredient in a therapeutic agent for inflammatory disease induced by sphingosylphosphorylcholine (SPC). The 2,4,5-trisubstiuted-l,3-thiazole derivative of the present invention has been confirmed to have superior inhibition activity against SPC receptor in an animal experiment using human-derived endothelial cells and mice. Thus, a pharmaceutical composition for treating inflammatory disease containing the 2,4,5-trisubstiuted-l,3-thiazole derivative or a pharmaceutically acceptable salt thereof as an effective ingredient may be useful for treating inflammation, itching or skin infection associated with atopic dermatitis or other disease induced by SPC receptor.
摘要翻译：本发明提供由以下化学式1表示的2,4,5-三溴代-1,3-噻唑衍生物，其药学上可接受的盐，其制备方法及其作为治疗剂的有效成分的用途由鞘氨醇磷酰胆碱（SPC）引起的炎性疾病。在使用人源性内皮细胞和小鼠的动物实验中，已证实本发明的2,4,5-三溴代-1,3-噻唑衍生物对SPC受体具有优异的抑制活性。因此，用于治疗含有2,4,5-三溴代-1,3-噻唑衍生物或其药学上可接受的盐作为有效成分的炎性疾病的药物组合物可用于治疗与特应性皮炎相关的炎症，瘙痒或皮肤感染或由SPC受体诱导的其他疾病。

9. 发明申请

WO2007094605A1 TOPICAL PREPARATION COMPOSITION CONTAINING A THIOUREA DERIVATIVE FOR PREVENTING OR TREATING PRURITIC OR IRRITANT SKIN DISEASES 审中-公开
标题翻译：含有用于预防或治疗有害或刺激性皮肤病的硫脲衍生物的局部制剂组合物
公开(公告)号：WO2007094605A1
公开(公告)日：2007-08-23
申请号：PCT/KR2007/000778
申请日：2007-02-14
申请人： AMOREPACIFIC CORPORATION , KIM, Dae Kwon , KIM, Kwang Mi , SUNG, Dae-Seok , PARK, Jong Hee , KIM, Hyoung June , YUN, Jun Won , PARK, Young-Ho , LIM, Kyung Min , CHOI, Jin Kyu , KOH, Hyun Ju , JEONG, Yeon Su , LEE, Chang Hoon , KIM, Jung Ju
发明人： KIM, Dae Kwon , KIM, Kwang Mi , SUNG, Dae-Seok , PARK, Jong Hee , KIM, Hyoung June , YUN, Jun Won , PARK, Young-Ho , LIM, Kyung Min , CHOI, Jin Kyu , KOH, Hyun Ju , JEONG, Yeon Su , LEE, Chang Hoon , KIM, Jung Ju
IPC分类号： A61K31/17 , A61K9/10 , A61K9/107 , A61P17/10 , A61P17/04
CPC分类号： A61K9/0014 , A61K31/17 , A61K47/10 , A61K47/12 , A61K47/20 , A61K47/26 , A61K47/32
摘要： The present invention relates to a topical composition comprising a thiourea derivative, which is a vanilloid receptor antagonist, and a pharmaceutically acceptable carrier and a pharmaceutical use of the same. The topical composition according to the present invention is excellent in skin permeation and stability and effective in treatment of pruritic or irritant skin diseases.
摘要翻译：本发明涉及一种局部组合物，其包含硫脲衍生物，其为香草酸受体拮抗剂，以及药学上可接受的载体及其药学用途。本发明的局部用组合物的皮肤渗透性和稳定性优异，且治疗瘙痒或刺激性皮肤病有效。

10. 发明申请

WO2006049451A1 USE OF SPHINGOSYLPHOSPHORYLCHOLINE OR THE DERIVATIVE THEREOF 审中-公开
标题翻译：磷脂酰基胆碱的使用或其衍生物
公开(公告)号：WO2006049451A1
公开(公告)日：2006-05-11
申请号：PCT/KR2005/003711
申请日：2005-11-04
申请人： AMOREPACIFIC CORPORATION , KIM, Hyoung June , YUN, Jun Won , KIM, Dae Kwon , PARK, Won Seok , SUNG, Dae Seok , YANG, Hye Jin , KIM, Kwang Mi , LEE, Chang Hoon , SIM, Young Chul
发明人： KIM, Hyoung June , YUN, Jun Won , KIM, Dae Kwon , PARK, Won Seok , SUNG, Dae Seok , YANG, Hye Jin , KIM, Kwang Mi , LEE, Chang Hoon , SIM, Young Chul
IPC分类号： A61K31/685
CPC分类号： A61K31/685
摘要： The present invention relates to a use of sphingosylphosphorylcholine or derivatives thereof, more particularly to a process for inducing an itch in an animal, a process for screening an anti-itching substance and a process for evaluating the anti-itching effect of an anti-itching substance, by regulating the administration of sphingosylphosphorylcholine. Sphingosylphosphorylcholine or derivatives thereof according to the present invention are useful in understanding an itch, for screening the curing agents for an itch, and for evaluating and developing such agent.
摘要翻译：本发明涉及鞘糖基磷酰胆碱或其衍生物的用途，更具体地涉及诱导动物瘙痒的方法，用于筛选抗瘙痒物质的方法和用于评价抗瘙痒的抗瘙痒效果的方法物质，通过调节鞘氨醇磷酰胆碱的施用。根据本发明的鞘氨酰磷酰胆碱或其衍生物可用于理解瘙痒，用于筛选瘙痒的固化剂，以及用于评价和开发该药剂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式